http://blogs.roanoke.com/chatscan/ar...03/post_2.html

Forbes magazine: Expectations high for Radford drugmaker
Excerpts:
According to a recent Forbes piece, "a lot of people have their fingers
crossed" that New River Pharmaceuticals Inc. will successfully launch its
planned new treatment for attention-deficit hyperactivity disorder with
partner Shire Plc.

Meanwhile, New River's 10-K says that:

.. U.S. consumers bought $1.2 billion worth of ADHD drugs in 2002. Sales
could reach $3 billion by 2009.